المؤلفون: Sakkas, A, Heil, S, Kargus, S, Rebel, M, Mischkowski, RA, Thiele, OC

المصدر: GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW; VOL: 10; DOC03 /20210414/

مصطلحات موضوعية: medication-related osteonecrosis of the jaw, tocilizumab, interleukin-6 receptor inhibitors, rheumatoid arthritis, osteomyelitis, medikamentenbedingte Osteonekrose des Kiefers, Interleukin-6-Rezeptor-Inhibitoren, rheumatoide Arthritis, ddc: 610

Relation: Allegra A, Oteri G, Alonci A, Bacci F, Penna G, Minardi V, Maisano V, Musolino C. Association of osteonecrosis of the jaws and POEMS syndrome in a patient assuming rituximab. J Craniomaxillofac Surg. 2014 Jun;42(4):279-82. DOI:10.1016/j.jcms.2013.05.014; Bennardo F, Buffone C, Giudice A. New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws. Oral Oncol. 2020 Jul;106:104659. DOI:10.1016/j.oraloncology.2020.104659; Bindakhil MA, Mupparapu M. Osteomyelitis of the mandible exhibiting features of medication-related osteonecrosis in a patient with history of tocilizumab treatment. J Orofac Sci. 2018;10(1):153-5.; Brijs K, Miclotte I, Vermeire S, Darche V, Politis C. Osteonecrosis of the jaw in patients with inflammatory bowel disease treated with tumour necrosis factor alpha inhibitors. Int J Oral Maxillofac Surg. 2020 Mar;49(3):317-24. DOI:10.1016/j.ijom.2019.08.007; Cassoni A, Romeo U, Terenzi V, Della Monaca M, Rajabtork Zadeh O, Raponi I, Fadda MT, Polimeni A, Valentini V. Adalimumab: Another Medication Related to Osteonecrosis of the Jaws? Case Rep Dent. 2016;2016:2856926. DOI:10.1155/2016/2856926; Chaitow J, De Benedetti F, Brunner H, Ruperto N, Allen R, Murray K, Schneider R, Woo P, Wright S, Kenwright A, Martini A, Lovell D. Tocilizumab in patients with systemic juvenile idiopathic arthritis; Efficacy data from the placebo-controlled 12-week part of the phase III Tender Trial. Intern Med J. 2011;41(s1):32. DOI:10.1111/j.1445-5994.2010.02466.x; Ciantar M, Adlam DM. Treatment with infliximab: Implications in oral surgery? A case report. Br J Oral Maxillofac Surg. 2007 Sep;45(6):507-10. DOI:10.1016/j.bjoms.2006.06.004; Dinnendahl V, Fricke U, editors. Arzneistoff-Profile. 4 (23 ed.). Eschborn, Germany: Govi Pharmazeutischer Verlag; 2010. ISBN: 978-3-7741-9846-3.; Ebker T, Rech J, von Wilmowsky C, Neukam FW, Stockmann P. Fulminant course of osteonecrosis of the jaw in a rheumatoid arthritis patient following oral bisphosphonate intake and biologic therapy. Rheumatology (Oxford). 2013 Jan;52(1):218-20. DOI:10.1093/rheumatology/kes351; Fleisher KE, Jolly A, Venkata UD, Norman RG, Saxena D, Glickman RS. Osteonecrosis of the jaw onset times are based on the route of bisphosphonate therapy. J Oral Maxillofac Surg. 2013 Mar;71(3):513-9. DOI:10.1016/j.joms.2012.07.049; Fleissig Y, Regev E, Lehman H. Sunitinib related osteonecrosis of jaw: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Mar;113(3):e1-3. DOI:10.1016/j.tripleo.2011.06.023; Goda H, Nakashiro KI, Hino S, Tanaka H, Hamakawa T, Hamakawa H. Possible negative effect of tocilizumab on BRONJ in a patient with methotrexate-associated lymphproliferative disorder. Nippon Koku Geka Gakkai Zasshi. 2013;59(5):346-51. DOI:10.5794/jjoms.59.346; Imaculada de Queiroz Rodrigues M, Ohana de Lima Martins J, Silva PGB, Carlos Ferreira Júnior AE, Quezado Lima Verde ME, Sousa FB, Lima Mota MR, Negreiros Nunes Alves AP. Tocilizumab, a Potent Interleukin-6 Receptor Inhibitor, Decreases Bone Resorption and Increases the Rate of Bacterial Infection After Tooth Extraction in Rats. J Oral Maxillofac Surg. 2020 Dec;78(12):2138-46. DOI:10.1016/j.joms.2020.08.012; Jones G, Sebba A, Gu J, Lowenstein MB, Calvo A, Gomez-Reino JJ, Siri DA, Tomsic M, Alecock E, Woodworth T, Genovese MC. Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Ann Rheum Dis. 2010 Jan;69(1):88-96. DOI:10.1136/ard.2008.105197; Kallen KJ. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochim Biophys Acta. 2002 Nov;1592(3):323-43. DOI:10.1016/s0167-4889(02)00325-7; Lescaille G, Coudert AE, Baaroun V, Ostertag A, Charpentier E, Javelot MJ, Tolédo R, Goudot P, Azérad J, Berdal A, Spano JP, Ruhin B, Descroix V. Clinical study evaluating the effect of bevacizumab on the severity of zoledronic acid-related osteonecrosis of the jaw in cancer patients. Bone. 2014 Jan;58:103-7. DOI:10.1016/j.bone.2013.10.002; Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J. Tocilizumab treatment in COVID-19: A single center experience. J Med Virol. 2020 Jul;92(7):814-8. DOI:10.1002/jmv.25801; Marx RE, Cillo JE Jr, Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg. 2007 Dec;65(12):2397-410. DOI:10.1016/j.joms.2007.08.003; Nishimoto N, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Azuma J. Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study. Ann Rheum Dis. 2009 Oct;68(10):1580-4. DOI:10.1136/ard.2008.092866; Pakosch D, Papadimas D, Munding J, Kawa D, Kriwalsky MS. Osteonecrosis of the mandible due to anti-angiogenic agent, bevacizumab. Oral Maxillofac Surg. 2013 Dec;17(4):303-6. DOI:10.1007/s10006-012-0379-9; Pichardo SE, van Merkesteyn JP. Evaluation of a surgical treatment of denosumab-related osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Sep;122(3):272-8. DOI:10.1016/j.oooo.2016.03.008; Preidl RH, Ebker T, Raithel M, Wehrhan F, Neukam FW, Stockmann P. Osteonecrosis of the jaw in a Crohn's disease patient following a course of Bisphosphonate and Adalimumab therapy: a case report. BMC Gastroenterol. 2014 Jan;14:6. DOI:10.1186/1471-230X-14-6; Ramírez L, López-Pintor RM, Casañas E, Arriba Ld, Hernández G. New Non-Bisphosphonate Drugs that Produce Osteonecrosis of the Jaws. Oral Health Prev Dent. 2015;13(5):385-93. DOI:10.3290/j.ohpd.a34055; Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O'Ryan F; American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg. 2014 Oct;72(10):1938-56. DOI:10.1016/j.joms.2014.04.031; Sandborn WJ, Hanauer SB. Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflamm Bowel Dis. 1999 May;5(2):119-33. DOI:10.1097/00054725-199905000-00008; Santos-Silva AR, Belizário Rosa GA, Castro Júnior Gd, Dias RB, Prado Ribeiro AC, Brandão TB. Osteonecrosis of the mandible associated with bevacizumab therapy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Jun;115(6):e32-6. DOI:10.1016/j.oooo.2013.02.001; Sivolella S, Lumachi F, Stellini E, Favero L. Denosumab and anti-angiogenetic drug-related osteonecrosis of the jaw: an uncommon but potentially severe disease. Anticancer Res. 2013 May;33(5):1793-7.; Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M; STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Int J Surg. 2014 Dec;12(12):1500-24. DOI:10.1016/j.ijsu.2014.07.014; Xu X, Han M, Li T, Sun W, Wang D, Fu B, Zhou Y, Zheng X, Yang Y, Li X, Zhang X, Pan A, Wei H. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A. 2020 May;117(20):10970-5. DOI:10.1073/pnas.2005615117; http://dx.doi.org/10.3205/iprs000153; http://nbn-resolving.de/urn:nbn:de:0183-iprs0001537; http://www.egms.de/en/journals/iprs/2021-10/iprs000153.shtml

الاتاحة: https://doi.org/10.3205/iprs000153
http://nbn-resolving.de/urn:nbn:de:0183-iprs0001537
http://www.egms.de/en/journals/iprs/2021-10/iprs000153.shtml

المؤلفون: Sakkas, A, Nolte, I, Heil, S, Mayer, B, Kargus, S, Mischkowski, RA, Thiele, OC

المصدر: GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW; VOL: 10; DOC02 /20210414/

مصطلحات موضوعية: Eggerthia catenaformis, anaerobic bacteria, dental abscess, osteomyelitis of the jaw, perihepatic abscesss, Anaerobier, Zahnabszess, odontogener Abszess, Osteomyelitis Kiefer, perihepatischer Abszess, ddc: 610

Relation: Akashi M, Tanaka K, Kusumoto J, Furudoi S, Hosoda K, Komori T. Brain Abscess Potentially Resulting from Odontogenic Focus: Report of Three Cases and a Literature Review. J Maxillofac Oral Surg. 2017 Mar;16(1):58-64. DOI:10.1007/s12663-016-0915-5; Duport P, Miltgen G, Kebbabi C, Belmonte O, Coolen-Allou N, Allyn J, Allou N. First case of pleural empyema and pulmonary abscess caused by Eggerthia catenaformis. Anaerobe. 2018 Apr;50:9-11. DOI:10.1016/j.anaerobe.2018.01.006; Kordjian HH, Schultz JD, Rosenvinge FS, Møller J, Pedersen RM. First clinical description of Eggerthia catenaformis bacteremia in a patient with dental abscess. Anaerobe. 2015 Oct;35(Pt B):38-40. DOI:10.1016/j.anaerobe.2015.07.002; Pereira RS, Bonardi JP, Ferreira A, Latini GL. An unusual case of dental infection by Pseudomonas aeruginosa causing a brain abscess: case report. Aust Dent J. 2017 Dec;62(4):523-7. DOI:10.1111/adj.12539; Rahman MA, Mullany P, Roberts AP. Draft Genome Sequence of Strain MAR1 Isolated from Saliva of Healthy Humans. Genome Announc. 2017 Jul;5(28):e00638-17. DOI:10.1128/genomeA.00638-17; Salvetti E, Felis GE, Dellaglio F, Castioni A, Torriani S, Lawson PA. Reclassification of Lactobacillus catenaformis (Eggerth 1935) Moore and Holdeman 1970 and Lactobacillus vitulinus Sharpe et al. 1973 as Eggerthia catenaformis gen. nov., comb. nov. and Kandleria vitulina gen. nov., comb. nov., respectively. Int J Syst Evol Microbiol. 2011 Oct;61(Pt 10):2520-4. DOI:10.1099/ijs.0.029231-0; Stein GE, Schooley S, Tyrrell KL, Citron DM, Nicolau DP, Goldstein EJ. Serum bactericidal activities of moxifloxacin and levofloxacin against aerobic and anaerobic intra-abdominal pathogens. Anaerobe. 2008 Feb;14(1):8-12. DOI:10.1016/j.anaerobe.2007.09.005; Yang J, Liu SY, Hossaini-Zadeh M, Pogrel MA. Brain abscess potentially secondary to odontogenic infection: case report. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Feb;117(2):e108-11. DOI:10.1016/j.oooo.2013.08.011; http://dx.doi.org/10.3205/iprs000152; http://nbn-resolving.de/urn:nbn:de:0183-iprs0001528; http://www.egms.de/en/journals/iprs/2021-10/iprs000152.shtml

الاتاحة: https://doi.org/10.3205/iprs000152
http://nbn-resolving.de/urn:nbn:de:0183-iprs0001528
http://www.egms.de/en/journals/iprs/2021-10/iprs000152.shtml

Additional Titles: Tocilizumab: Noch eine Medikation im Zusammenhang mit Osteonekrose des Kiefers? Ein Fallbericht und Literaturübersicht

المؤلفون: Sakkas, A, Heil, S, Kargus, S, Rebel, M, Mischkowski, RA, Thiele, OC

المصدر: GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW; VOL: 10; DOC03 /20210414/

مصطلحات الفهرس: medication-related osteonecrosis of the jaw, tocilizumab, interleukin-6 receptor inhibitors, rheumatoid arthritis, osteomyelitis, medikamentenbedingte Osteonekrose des Kiefers, Tocilizumab, Interleukin-6-Rezeptor-Inhibitoren, rheumatoide Arthritis, Osteomyelitis, ddc: 610, article

URL: http://nbn-resolving.de/urn:nbn:de:0183-iprs0001537
http://www.egms.de/en/journals/iprs/2021-10/iprs000153.shtml
Allegra A, Oteri G, Alonci A, Bacci F, Penna G, Minardi V, Maisano V, Musolino C. Association of osteonecrosis of the jaws and POEMS syndrome in a patient assuming rituximab. J Craniomaxillofac Surg. 2014 Jun;42(4):279-82. DOI: 10.1016/j.jcms.2013.05.014
Bennardo F, Buffone C, Giudice A. New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws. Oral Oncol. 2020 Jul;106:104659. DOI: 10.1016/j.oraloncology.2020.104659
Bindakhil MA, Mupparapu M. Osteomyelitis of the mandible exhibiting features of medication-related osteonecrosis in a patient with history of tocilizumab treatment. J Orofac Sci. 2018;10(1):153-5.
Brijs K, Miclotte I, Vermeire S, Darche V, Politis C. Osteonecrosis of the jaw in patients with inflammatory bowel disease treated with tumour necrosis factor alpha inhibitors. Int J Oral Maxillofac Surg. 2020 Mar;49(3):317-24. DOI: 10.1016/j.ijom.2019.08.007
Cassoni A, Romeo U, Terenzi V, Della Monaca M, Rajabtork Zadeh O, Raponi I, Fadda MT, Polimeni A, Valentini V. Adalimumab: Another Medication Related to Osteonecrosis of the Jaws? Case Rep Dent. 2016;2016:2856926. DOI: 10.1155/2016/2856926
Cassoni A, Romeo U, Terenzi V, Della Monaca M, Rajabtork Zadeh O, Raponi I, Fadda MT, Polimeni A, Valentini V. Adalimumab: Another Medication Related to Osteonecrosis of the Jaws? Case Rep Dent. 2016;2016:2856926. DOI: 10.1155/2016/2856926
Chaitow J, De Benedetti F, Brunner H, Ruperto N, Allen R, Murray K, Schneider R, Woo P, Wright S, Kenwright A, Martini A, Lovell D. Tocilizumab in patients with systemic juvenile idiopathic arthritis; Efficacy data from the placebo-controlled 12-week part of the phase III Tender Trial. Intern Med J. 2011;41(s1):32. DOI: 10.1111/j.1445-5994.2010.02466.x
Ciantar M, Adlam DM. Treatment with infliximab: Implications in oral surgery? A case report. Br J Oral Maxillofac Surg. 2007 Sep;45(6):507-10. DOI: 10.1016/j.bjoms.2006.06.004
Dinnendahl V, Fricke U, editors. Arzneistoff-Profile. 4 (23 ed.). Eschborn, Germany: Govi Pharmazeutischer Verlag; 2010. ISBN: 978-3-7741-9846-3.
Ebker T, Rech J, von Wilmowsky C, Neukam FW, Stockmann P. Fulminant course of osteonecrosis of the jaw in a rheumatoid arthritis patient following oral bisphosphonate intake and biologic therapy. Rheumatology (Oxford). 2013 Jan;52(1):218-20. DOI: 10.1093/rheumatology/kes351
Fleisher KE, Jolly A, Venkata UD, Norman RG, Saxena D, Glickman RS. Osteonecrosis of the jaw onset times are based on the route of bisphosphonate therapy. J Oral Maxillofac Surg. 2013 Mar;71(3):513-9. DOI: 10.1016/j.joms.2012.07.049
Fleissig Y, Regev E, Lehman H. Sunitinib related osteonecrosis of jaw: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Mar;113(3):e1-3. DOI: 10.1016/j.tripleo.2011.06.023
Fleissig Y, Regev E, Lehman H. Sunitinib related osteonecrosis of jaw: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Mar;113(3):e1-3. DOI: 10.1016/j.tripleo.2011.06.023
Goda H, Nakashiro KI, Hino S, Tanaka H, Hamakawa T, Hamakawa H. Possible negative effect of tocilizumab on BRONJ in a patient with methotrexate-associated lymphproliferative disorder. Nippon Koku Geka Gakkai Zasshi. 2013;59(5):346-51. DOI: 10.5794/jjoms.59.346
Imaculada de Queiroz Rodrigues M, Ohana de Lima Martins J, Silva PGB, Carlos Ferreira Júnior AE, Quezado Lima Verde ME, Sousa FB, Lima Mota MR, Negreiros Nunes Alves AP. Tocilizumab, a Potent Interleukin-6 Receptor Inhibitor, Decreases Bone Resorption and Increases the Rate of Bacterial Infection After Tooth Extraction in Rats. J Oral Maxillofac Surg. 2020 Dec;78(12):2138-46. DOI: 10.1016/j.joms.2020.08.012
Jones G, Sebba A, Gu J, Lowenstein MB, Calvo A, Gomez-Reino JJ, Siri DA, Tomsic M, Alecock E, Woodworth T, Genovese MC. Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Ann Rheum Dis. 2010 Jan;69(1):88-96. DOI: 10.1136/ard.2008.105197
Kallen KJ. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochim Biophys Acta. 2002 Nov;1592(3):323-43. DOI: 10.1016/s0167-4889(02)00325-7
Lescaille G, Coudert AE, Baaroun V, Ostertag A, Charpentier E, Javelot MJ, Tolédo R, Goudot P, Azérad J, Berdal A, Spano JP, Ruhin B, Descroix V. Clinical study evaluating the effect of bevacizumab on the severity of zoledronic acid-related osteonecrosis of the jaw in cancer patients. Bone. 2014 Jan;58:103-7. DOI: 10.1016/j.bone.2013.10.002
Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J. Tocilizumab treatment in COVID-19: A single center experience. J Med Virol. 2020 Jul;92(7):814-8. DOI: 10.1002/jmv.25801
Marx RE, Cillo JE Jr, Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg. 2007 Dec;65(12):2397-410. DOI: 10.1016/j.joms.2007.08.003
Nishimoto N, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Azuma J. Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study. Ann Rheum Dis. 2009 Oct;68(10):1580-4. DOI: 10.1136/ard.2008.092866
Pakosch D, Papadimas D, Munding J, Kawa D, Kriwalsky MS. Osteonecrosis of the mandible due to anti-angiogenic agent, bevacizumab. Oral Maxillofac Surg. 2013 Dec;17(4):303-6. DOI: 10.1007/s10006-012-0379-9
Pichardo SE, van Merkesteyn JP. Evaluation of a surgical treatment of denosumab-related osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Sep;122(3):272-8. DOI: 10.1016/j.oooo.2016.03.008
Pichardo SE, van Merkesteyn JP. Evaluation of a surgical treatment of denosumab-related osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Sep;122(3):272-8. DOI: 10.1016/j.oooo.2016.03.008
Preidl RH, Ebker T, Raithel M, Wehrhan F, Neukam FW, Stockmann P. Osteonecrosis of the jaw in a Crohn's disease patient following a course of Bisphosphonate and Adalimumab therapy: a case report. BMC Gastroenterol. 2014 Jan;14:6. DOI: 10.1186/1471-230X-14-6
Ramírez L, López-Pintor RM, Casañas E, Arriba Ld, Hernández G. New Non-Bisphosphonate Drugs that Produce Osteonecrosis of the Jaws. Oral Health Prev Dent. 2015;13(5):385-93. DOI: 10.3290/j.ohpd.a34055
Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O'Ryan F; American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg. 2014 Oct;72(10):1938-56. DOI: 10.1016/j.joms.2014.04.031
Sandborn WJ, Hanauer SB. Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflamm Bowel Dis. 1999 May;5(2):119-33. DOI: 10.1097/00054725-199905000-00008
Santos-Silva AR, Belizário Rosa GA, Castro Júnior Gd, Dias RB, Prado Ribeiro AC, Brandão TB. Osteonecrosis of the mandible associated with bevacizumab therapy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Jun;115(6):e32-6. DOI: 10.1016/j.oooo.2013.02.001
Sivolella S, Lumachi F, Stellini E, Favero L. Denosumab and anti-angiogenetic drug-related osteonecrosis of the jaw: an uncommon but potentially severe disease. Anticancer Res. 2013 May;33(5):1793-7.
Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M; STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Int J Surg. 2014 Dec;12(12):1500-24. DOI: 10.1016/j.ijsu.2014.07.014
Xu X, Han M, Li T, Sun W, Wang D, Fu B, Zhou Y, Zheng X, Yang Y, Li X, Zhang X, Pan A, Wei H. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A. 2020 May;117(20):10970-5. DOI: 10.1073/pnas.2005615117

Additional Titles: Von einem Zahnabszess ausgehende Eggerthia catenaformis-Infektion verursacht schwere Darmkomplikationen und Osteomyelitis des Kiefers

المؤلفون: Sakkas, A, Nolte, I, Heil, S, Mayer, B, Kargus, S, Mischkowski, RA, Thiele, OC

المصدر: GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW; VOL: 10; DOC02 /20210414/

مصطلحات الفهرس: Eggerthia catenaformis, anaerobic bacteria, dental abscess, osteomyelitis of the jaw, perihepatic abscesss, Anaerobier, Zahnabszess, odontogener Abszess, Osteomyelitis Kiefer, perihepatischer Abszess, ddc: 610, article

URL: http://nbn-resolving.de/urn:nbn:de:0183-iprs0001528
http://www.egms.de/en/journals/iprs/2021-10/iprs000152.shtml
Akashi M, Tanaka K, Kusumoto J, Furudoi S, Hosoda K, Komori T. Brain Abscess Potentially Resulting from Odontogenic Focus: Report of Three Cases and a Literature Review. J Maxillofac Oral Surg. 2017 Mar;16(1):58-64. DOI: 10.1007/s12663-016-0915-5
Duport P, Miltgen G, Kebbabi C, Belmonte O, Coolen-Allou N, Allyn J, Allou N. First case of pleural empyema and pulmonary abscess caused by Eggerthia catenaformis. Anaerobe. 2018 Apr;50:9-11. DOI: 10.1016/j.anaerobe.2018.01.006
Kordjian HH, Schultz JD, Rosenvinge FS, Møller J, Pedersen RM. First clinical description of Eggerthia catenaformis bacteremia in a patient with dental abscess. Anaerobe. 2015 Oct;35(Pt B):38-40. DOI: 10.1016/j.anaerobe.2015.07.002
Pereira RS, Bonardi JP, Ferreira A, Latini GL. An unusual case of dental infection by Pseudomonas aeruginosa causing a brain abscess: case report. Aust Dent J. 2017 Dec;62(4):523-7. DOI: 10.1111/adj.12539
Rahman MA, Mullany P, Roberts AP. Draft Genome Sequence of Strain MAR1 Isolated from Saliva of Healthy Humans. Genome Announc. 2017 Jul;5(28):e00638-17. DOI: 10.1128/genomeA.00638-17
Salvetti E, Felis GE, Dellaglio F, Castioni A, Torriani S, Lawson PA. Reclassification of Lactobacillus catenaformis (Eggerth 1935) Moore and Holdeman 1970 and Lactobacillus vitulinus Sharpe et al. 1973 as Eggerthia catenaformis gen. nov., comb. nov. and Kandleria vitulina gen. nov., comb. nov., respectively. Int J Syst Evol Microbiol. 2011 Oct;61(Pt 10):2520-4. DOI: 10.1099/ijs.0.029231-0
Stein GE, Schooley S, Tyrrell KL, Citron DM, Nicolau DP, Goldstein EJ. Serum bactericidal activities of moxifloxacin and levofloxacin against aerobic and anaerobic intra-abdominal pathogens. Anaerobe. 2008 Feb;14(1):8-12. DOI: 10.1016/j.anaerobe.2007.09.005
Yang J, Liu SY, Hossaini-Zadeh M, Pogrel MA. Brain abscess potentially secondary to odontogenic infection: case report. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Feb;117(2):e108-11. DOI: 10.1016/j.oooo.2013.08.011

المؤلفون: Neugebauer J, Ritter L, Mischkowski RA, Dreiseidler T, Scherer P, Ketterle M, Rothamel D, Zoller JE

المصدر: International Journal of Oral & Maxillofacial Implants; 2010 Mar-Apr, Vol. 25 Issue 2, p258-265, 8p

المؤلفون: Neugebauer J, Scheer M, Mischkowski RA, An S, Karapetian VE, Toutenburg H, Zoeller JE

المصدر: International Journal of Oral & Maxillofacial Implants; 2009, Vol. 24 Issue 3, p469-476, 8p

المؤلفون: Rothamel D, Schwarz F, Herten M, Ferrari D, Mischkowski RA, Sager M, Becker J

المصدر: International Journal of Oral & Maxillofacial Implants; 2009, Vol. 24 Issue 2, p243-250, 8p

المؤلفون: Dreiseidler T, Mischkowski RA, Neugebauer J, Ritter L, Zoller JE

المصدر: International Journal of Oral & Maxillofacial Implants; 2009, Vol. 24 Issue 2, p216-225, 10p

المؤلفون: Mischkowski RA, Ritter L, Neugebauer J, Dreiseidler T, Keeve E, Zöller JE

المصدر: Quintessence International; Oct2007, Vol. 38 Issue 9, p763-772, 10p

المؤلفون: Dreiseidler T, Alarabi N, Ritter L, Rothamel D, Scheer M, Zöller JE, Mischkowski RA

المصدر: Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology & Endodontology; Sep2011, Vol. 112 Issue 3, p367-374, 8p